메뉴 건너뛰기




Volumn 16, Issue 3, 2007, Pages 317-326

Neuronal vulnerability of CLN3 deletion to calcium-induced cytotoxicity is mediated by calsenilin

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCIUM BINDING PROTEIN; CALCIUM ION; CALSENILIN; MEMBRANE PROTEIN; MUTANT PROTEIN; THAPSIGARGIN;

EID: 33847281052     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl466     Document Type: Article
Times cited : (46)

References (46)
  • 1
    • 0031721511 scopus 로고    scopus 로고
    • Calasenilin, a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
    • Buxbaum, J.D., Choi, E.K., Luo, Y., Lilliehook, C., Crowley, A.C., Merriam, D.E. and Wasco, W. (1998) Calasenilin, a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med., 4, 1177-1181.
    • (1998) Nat. Med. , vol.4 , pp. 1177-1181
    • Buxbaum, J.D.1    Choi, E.K.2    Luo, Y.3    Lilliehook, C.4    Crowley, A.C.5    Merriam, D.E.6    Wasco, W.7
  • 5
    • 0942276796 scopus 로고    scopus 로고
    • Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-β exposure
    • Jo, D.G., Lee, J.Y., Hong, Y.M., Song, S., Mook-Jung, I., Koh, J.Y. and Jung, Y.K. (2004) Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-β exposure. J. Neurochem., 88, 604-611.
    • (2004) J. Neurochem. , vol.88 , pp. 604-611
    • Jo, D.G.1    Lee, J.Y.2    Hong, Y.M.3    Song, S.4    Mook-Jung, I.5    Koh, J.Y.6    Jung, Y.K.7
  • 9
    • 0035374675 scopus 로고    scopus 로고
    • Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2
    • Choi, E.K., Zaidi, N.F., Miller, J.S., Crowley, A.C., Merriam, D.E., Lilliehook, C., Buxbaum, J.D. and Wasco, W. (2001) Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2. J. Biol. Chem., 276, 19197-19204.
    • (2001) J. Biol. Chem. , vol.276 , pp. 19197-19204
    • Choi, E.K.1    Zaidi, N.F.2    Miller, J.S.3    Crowley, A.C.4    Merriam, D.E.5    Lilliehook, C.6    Buxbaum, J.D.7    Wasco, W.8
  • 11
    • 0037417183 scopus 로고    scopus 로고
    • Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients
    • Hong, Y.M., Jo, D.G., Lee, M.C., Kim, S.Y. and Jung, Y.K. (2003) Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients. Neurosci. Lett., 340, 33-36.
    • (2003) Neurosci. Lett. , vol.340 , pp. 33-36
    • Hong, Y.M.1    Jo, D.G.2    Lee, M.C.3    Kim, S.Y.4    Jung, Y.K.5
  • 12
    • 0029147298 scopus 로고
    • Isolation of a novel gene underlying Batten disease, CLN3
    • Batten Disease Consortium, International
    • Batten Disease Consortium, International (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell, 82, 949-957.
    • (1995) Cell , vol.82 , pp. 949-957
  • 14
    • 0034701293 scopus 로고    scopus 로고
    • Batten disease: Evaluation of CLN3 mutations on protein localization and function
    • Haskell, R.E., Carr, C.J., Pearce, D.A., Bennett, M.J. and Davidson, B.L. (2000) Batten disease: Evaluation of CLN3 mutations on protein localization and function. Hum. Mol. Genet., 9, 735-744.
    • (2000) Hum. Mol. Genet. , vol.9 , pp. 735-744
    • Haskell, R.E.1    Carr, C.J.2    Pearce, D.A.3    Bennett, M.J.4    Davidson, B.L.5
  • 15
    • 1542313968 scopus 로고    scopus 로고
    • Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells
    • Kyttälä, A., Ihrke, G., Vesa, J., Schell, M.J. and Luzio, J.P. (2003) Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells. Mol. Biol. Cell, 15, 1313-1323.
    • (2003) Mol. Biol. Cell , vol.15 , pp. 1313-1323
    • Kyttälä, A.1    Ihrke, G.2    Vesa, J.3    Schell, M.J.4    Luzio, J.P.5
  • 16
    • 0037226939 scopus 로고    scopus 로고
    • The neuronal ceroid-lipofucinoses
    • Haltia, M. (2003) The neuronal ceroid-lipofucinoses. J. Neuropathol. Exp. Neurol., 62, 1-13.
    • (2003) J. Neuropathol. Exp. Neurol. , vol.62 , pp. 1-13
    • Haltia, M.1
  • 17
    • 0026511672 scopus 로고
    • Neurology of the neuronal ceroid-lipofuscinoses: Late infantile and Juvenile types
    • Boustany, M. (1992) Neurology of the neuronal ceroid-lipofuscinoses: late infantile and Juvenile types. Am. J. Med. Ge., 42, 533-535.
    • (1992) Am. J. Med. Ge. , vol.42 , pp. 533-535
    • Boustany, M.1
  • 18
    • 0000118993 scopus 로고    scopus 로고
    • Batten disease or neuronal ceroid lipofuscinosis
    • In Vinken, P.J., Bruyn, G.W. and Moser, H.W. (eds), Elsevier Sciences, New York
    • Boustany, M. (1996) Batten disease or neuronal ceroid lipofuscinosis. In Vinken, P.J., Bruyn, G.W. and Moser, H.W. (eds), Handbook of Clinical Neurology, Neurodystrophies and Neurolipidoses, Elsevier Sciences, New York, Vol. 66, pp. 671-900.
    • (1996) Handbook of Clinical Neurology, Neurodystrophies and Neurolipidoses , vol.66 , pp. 671-900
    • Boustany, M.1
  • 19
    • 0042863233 scopus 로고    scopus 로고
    • Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis
    • Sappington, R.M., Pearce, D.A. and Calkins, D.J. (2003) Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis. Invest. Ophthalmol. Vis. Sci., 44, 3725-3731.
    • (2003) Invest. Ophthalmol. Vis. Sci. , vol.44 , pp. 3725-3731
    • Sappington, R.M.1    Pearce, D.A.2    Calkins, D.J.3
  • 21
    • 71749101489 scopus 로고    scopus 로고
    • An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease
    • Chattopadhyay, S., Ito, M., Cooper, J.D., Brooks, A.I., Curran, T.M., Powers, J.M. and Pearce, D.A. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum. Mol. Genet., 11, 1421-1431.
    • (2002) Hum. Mol. Genet. , vol.11 , pp. 1421-1431
    • Chattopadhyay, S.1    Ito, M.2    Cooper, J.D.3    Brooks, A.I.4    Curran, T.M.5    Powers, J.M.6    Pearce, D.A.7
  • 23
    • 0030038060 scopus 로고    scopus 로고
    • Apoptosis as the mechanism of neurodegeneration in Batten's disease
    • Lane, S.C., Jolly, R.D., Schmechel, D.E., Alroy, J. and Boustany, M. (1996) Apoptosis as the mechanism of neurodegeneration in Batten's disease. J. Neurochem., 67, 677-683.
    • (1996) J. Neurochem. , vol.67 , pp. 677-683
    • Lane, S.C.1    Jolly, R.D.2    Schmechel, D.E.3    Alroy, J.4    Boustany, M.5
  • 24
    • 0030740542 scopus 로고    scopus 로고
    • Morphologic diagnosis in neuronal ceroid lipofiscinoses
    • Goebel, H.H. (1997) Morphologic diagnosis in neuronal ceroid lipofiscinoses. Neuropediatrics, 28, 67-69.
    • (1997) Neuropediatrics , vol.28 , pp. 67-69
    • Goebel, H.H.1
  • 25
    • 0036712747 scopus 로고    scopus 로고
    • Motifs within the CLN3 protein: Modulation of cell growth rates and apoptosis
    • Persaud-Sawin, D.A., VanDongen, A. and Boustany, M. (2002) Motifs within the CLN3 protein: Modulation of cell growth rates and apoptosis. Hum. Mol. Genet., 11, 2129-2142.
    • (2002) Hum. Mol. Genet. , vol.11 , pp. 2129-2142
    • Persaud-Sawin, D.A.1    VanDongen, A.2    Boustany, M.3
  • 26
    • 0032799217 scopus 로고    scopus 로고
    • CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide
    • Puranam, K.L., Guo, W.-X., Qian, W.-H., Nikbakht, K. and Boustany, M. (1999) CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol. Gen. Met., 66, 294-308.
    • (1999) Mol. Gen. Met. , vol.66 , pp. 294-308
    • Puranam, K.L.1    Guo, W.-X.2    Qian, W.-H.3    Nikbakht, K.4    Boustany, M.5
  • 27
    • 24644471460 scopus 로고    scopus 로고
    • Cell death pathways in juvenile Batten disease
    • Persaud-Sawin, D.-A. and Boustany, M. (2005) Cell death pathways in juvenile Batten disease. Apoptosis, 10, 973-985.
    • (2005) Apoptosis , vol.10 , pp. 973-985
    • Persaud-Sawin, D.-A.1    Boustany, M.2
  • 29
    • 33646269496 scopus 로고    scopus 로고
    • Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy
    • Buytaert, E., Callewaert, G., Hendrickx, N., Scorrano, L., Hartmann, D., Missiaen, L., Vandenheede, J.R., Heirman, I., Grooten, J. and Agostinis, P. (2006) Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J., 20, 756-768.
    • (2006) FASEB J. , vol.20 , pp. 756-768
    • Buytaert, E.1    Callewaert, G.2    Hendrickx, N.3    Scorrano, L.4    Hartmann, D.5    Missiaen, L.6    Vandenheede, J.R.7    Heirman, I.8    Grooten, J.9    Agostinis, P.10
  • 32
    • 2042496266 scopus 로고    scopus 로고
    • Intracellular calcium modulates the nuclear translocation of calsenilin
    • Zaidi, N.F., Thomson, E.E., Choi, E.K., Buxbaum, J.D. and Wasco, W. (2004) Intracellular calcium modulates the nuclear translocation of calsenilin. J. Neurochem., 89, 593-601.
    • (2004) J. Neurochem. , vol.89 , pp. 593-601
    • Zaidi, N.F.1    Thomson, E.E.2    Choi, E.K.3    Buxbaum, J.D.4    Wasco, W.5
  • 35
    • 0344867852 scopus 로고    scopus 로고
    • Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
    • Järvelä, I., Lehtovirta, M., Tikknen, R., Kyttala, A. and Jalanko, A. (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum. Mol. Genet., 8, 1091-1098.
    • (1999) Hum. Mol. Genet. , vol.8 , pp. 1091-1098
    • Järvelä, I.1    Lehtovirta, M.2    Tikknen, R.3    Kyttala, A.4    Jalanko, A.5
  • 36
    • 0032905252 scopus 로고    scopus 로고
    • Action of BTN1, the yeast orthologue of the gene mutated in Batten disease
    • Pearce, D.A., Ferea, T., Nosel, S.A., Das, B. and Sherman, F. (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet., 22, 55-58.
    • (1999) Nat. Genet. , vol.22 , pp. 55-58
    • Pearce, D.A.1    Ferea, T.2    Nosel, S.A.3    Das, B.4    Sherman, F.5
  • 37
    • 0033764930 scopus 로고    scopus 로고
    • The yeast model for batten disease: Mutations in BTN1, BTN2 and HSP30 alter pH homeostasis
    • Chattopadhyay, S., Muzaffar, N.E., Sherman, F. and Pearce, D.A. (2000) The yeast model for batten disease: Mutations in BTN1, BTN2 and HSP30 alter pH homeostasis. J. Bacteriol., 22, 6418-6423.
    • (2000) J. Bacteriol. , vol.22 , pp. 6418-6423
    • Chattopadhyay, S.1    Muzaffar, N.E.2    Sherman, F.3    Pearce, D.A.4
  • 38
    • 28744438595 scopus 로고    scopus 로고
    • Defective lysosomal arginine transport in juvenile Batten disease
    • Ramirez-Montealegre, D. and Pearce, D.A. (2005) Defective lysosomal arginine transport in juvenile Batten disease. Hum. Mol. Genet., 14, 3759-3773.
    • (2005) Hum. Mol. Genet. , vol.14 , pp. 3759-3773
    • Ramirez-Montealegre, D.1    Pearce, D.A.2
  • 39
    • 0347364649 scopus 로고    scopus 로고
    • A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease
    • Kim, Y., Ramirez-Montealegre, D. and Pearce, D.A. (2003) A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc. Natl Acad. Sci. USA., 23, 15458-15462.
    • (2003) Proc. Natl Acad. Sci. USA , vol.23 , pp. 15458-15462
    • Kim, Y.1    Ramirez-Montealegre, D.2    Pearce, D.A.3
  • 43
    • 9744254471 scopus 로고    scopus 로고
    • Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway
    • Luiro, K., Yliannala, K., Ahtiainen, L., Maunu, H., Jarvela, I., Kyttala, A. and Jalanko, A. (2004) Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum. Mol. Genet., 13, 3017-3027.
    • (2004) Hum. Mol. Genet. , vol.13 , pp. 3017-3027
    • Luiro, K.1    Yliannala, K.2    Ahtiainen, L.3    Maunu, H.4    Jarvela, I.5    Kyttala, A.6    Jalanko, A.7
  • 44
    • 0036326358 scopus 로고    scopus 로고
    • Neuronal ceroid lipofuscinoses are connected at molecular level interaction of CLN5 protein with CLN2 and CLN3
    • Vesa, J., Chin, M.H., Oelgeschlager, K., Isosomppi, J., DellAngelica, E.C., Jalanko, A. and Peltonen, L. (2002) Neuronal ceroid lipofuscinoses are connected at molecular level interaction of CLN5 protein with CLN2 and CLN3. Mol. Biol. Cell, 13, 2410-2420.
    • (2002) Mol. Biol. Cell , vol.13 , pp. 2410-2420
    • Vesa, J.1    Chin, M.H.2    Oelgeschlager, K.3    Isosomppi, J.4    DellAngelica, E.C.5    Jalanko, A.6    Peltonen, L.7
  • 45
    • 0029977497 scopus 로고    scopus 로고
    • Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies
    • Kramer, H. and Phistry, M. (1996) Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies. J. Cell Biol., 133, 1205-1215.
    • (1996) J. Cell Biol. , vol.133 , pp. 1205-1215
    • Kramer, H.1    Phistry, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.